Value of albumin-bilirubin score in predicting the prognosis of patients with liver cirrhosis and esophagogastric variceal bleeding

Dezhao LI; Jian LI; Xiaolin GUO

doi:10.3969/j.issn.1001-5256.2021.05.022

Volume 37 Issue 5

May 2021

Turn off MathJax

Article Contents

Abstract

References

Article Navigation > Journal of Clinical Hepatology > 2021 > 37(5): 1085-1090

PDF( 2209 KB)

Value of albumin-bilirubin score in predicting the prognosis of patients with liver cirrhosis and esophagogastric variceal bleeding

DOI: 10.3969/j.issn.1001-5256.2021.05.022

Department of Hepatology, The First Hospital of Jilin University, Changchun 130000, China

Received Date: 2020-10-28
Accepted Date: 2020-12-04
Published Date: 2021-05-20

Abstract

Abstract

Objective To investigate the value of albumin-bilirubin (ALBI) score in evaluating the prognosis of patients with liver cirrhosis and esophagogastric variceal bleeding, and to compare it with Child-Turcotte-Pugh (CTP) score and Model for End-stage Liver Disease combined with serum sodium concentration (MELD-Na) score. Methods A retrospective analysis was performed for the clinical data of 155 patients who were diagnosed with liver cirrhosis and esophagogastric variceal bleeding in The First Hospital of Jilin University from August 2018 to April 2019, and according to disease outcome after 1 year of follow-up, these patients were divided into survival group with 98 patients and death group with 57 patients. The influencing factors for prognosis were analyzed, and the value of ALBI score in predicting prognosis was assessed. The t-test was used for comparison of normally distributed continuous data between two groups, and the Mann-Whitney U test was used for comparison of non-normally distributed continuous data between two groups; the chi-square test was used for comparison of categorical data between two groups. A Spearman correlation analysis was performed to investigate the correlation between two variables. A multivariate logistic regression analysis was used to investigate independent influencing factors for death within 1 year. The receiver operating characteristic (ROC) curve was plotted, and the area under the ROC curve (AUC) was calculated; the optimal cut-off value was determined based on Youden index. The Z test was used for comparison of AUC between these three scoring systems. Results There were significant differences between the survival group and the death group in initial blood loss (U=1994.5, P=0.002), presence or absence of hepatic encephalopathy (χ²=14.154, P < 0.001), severity of ascites (χ²=10.537, P=0.005), total bilirubin (U=1694.0, P < 0.001), albumin (t=-6.633, P < 0.001), aspartate aminotransferase (U=2223.5, P=0.035), Na (U=1859.5, P=0.001), international normalized ratio (U=1259.5, P < 0.001), prothrombin time (U=1331.5, P < 0.001), white blood cell count (U=2008.5, P=0.004), red blood cell count (t=-2.633, P=0.009), red blood cell volume distribution width (U=1719.5, P < 0.001), hemoglobin (U=2150.0, P=0.017), ALBI grade (χ²=48.732, P < 0.001), and CTP class (χ²=34.646, P < 0.001). The death group had a significantly higher ALBI score on admission than the survival group (-1.11±0.59 vs -1.79±0.44, t=7.618, P < 0.001), as well as significantly higher MELD-Na score (18.0[14.5-24.0] vs 12.0[10.0-16.0], U=1176.0, P < 0.001) and CTP score (9.0[8.0-11.0] vs 7.0[6.0-8.0], U=1078.0, P < 0.001). The Spearman correlation analysis showed that ALBI score was positively correlated with CTP score and MELD-Na score (r=0.753 and 0.668, both P < 0.001). The multivariate logistic regression analysis showed that ALBI score (odds ratio [OR]=8.349, 95% confidence interval [CI]: 2.658-26.232), CTP score (OR=1.586, 95%CI: 1.157-2.175), and MELD-Na score (OR=1.188, 95%CI: 1.062-1.328) were independent risk factors for predicting death within 1 year. The optimal cut-off value was -1.485 for ALBI score, 8.5 for CTP score, and 17.5 for MELD-Na score in predicting the 1-year prognosis of patients, with an AUC of 0.818, 0.807, and 0.789, respectively. There was no significant difference between the three scoring systems in predicting the 1-year mortality rate (P > 0.05). Conclusion The performance of ALBI score is comparable to that of CTP and MELD-Na scores in predicting the risk of death within 1 year in patients with liver cirrhosis and esophagogastric variceal bleeding, and ALBI score has a good evaluation ability.
- Liver Cirrhosis,
- Esophageal and Gastric Varices,
- Albumin-Bilirubin Score,
- Prognosis

FullText(HTML)

References(18)

References

[1]	Chinese Society of Hepatology, Chinese Medical Association. Chinese guidelines on the management of liver cirrhosis[J]. J Clin Hepatol, 2019, 35(11): 2408-2425. DOI: 10.3969/j.issn.1001-5256.2019.11.006. 中华医学会肝病学分会. 肝硬化诊治指南[J]. 临床肝胆病杂志, 2019, 35(11): 2408-2425. DOI: 10.3969/j.issn.1001-5256.2019.11.006.
[2]	SASS DA, CHOPRA KB. Portal hypertension and variceal hemorrhage[J]. Med Clin North Am, 2009, 93(4): 837-853, ⅶ-ⅷ. DOI: 10.1016/j.mcna.2009.03.008.
[3]	WAN SZ, NIE Y, ZHANG Y, et al. Assessing the prognostic performance of the Child-Pugh, Model for End-Stage Liver Disease, and Albumin-Bilirubin scores in patients with decompensated cirrhosis: A large asian cohort from gastroenterology department[J]. Dis Markers, 2020, 2020: 5193028. DOI: 10.1155/2020/5193028.
[4]	KAMATH PS, WIESNER RH, MALINCHOC M, et al. A model to predict survival in patients with end-stage liver disease[J]. Hepatology, 2001, 33(2): 464-470. DOI: 10.1053/jhep.2001.22172.
[5]	PUGH RN, MURRAY-LYON IM, DAWSON JL, et al. Transection of the oesophagus for bleeding oesophageal varices[J]. Br J Surg, 1973, 60(8): 646-649. DOI: 10.1002/bjs.1800600817.
[6]	CREMERS I, RIBEIRO S. Management of variceal and nonvariceal upper gastrointestinal bleeding in patients with cirrhosis[J]. Therap Adv Gastroenterol, 2014, 7(5): 206-216. DOI: 10.1177/1756283X14538688.
[7]	D'AMICO G, GARCIA-TSAO G, PAGLIARO L. Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies[J]. J Hepatol, 2006, 44(1): 217-231. DOI: 10.1016/j.jhep.2005.10.013.
[8]	JOHNSON PJ, BERHANE S, KAGEBAYASHI C, et al. Assessment of liver function in patients with hepatocellular carcinoma: A new evidence-based approach-the ALBI grade[J]. J Clin Oncol, 2015, 33(6): 550-558. DOI: 10.1200/JCO.2014.57.9151.
[9]	BIYIK M, UCAR R, SOLAK Y, et al. Blood neutrophil-to-lymphocyte ratio independently predicts survival in patients with liver cirrhosis[J]. Eur J Gastroenterol Hepatol, 2013, 25(4): 435-441. DOI: 10.1097/MEG.0b013e32835c2af3.
[10]	MALINCHOC M, KAMATH PS, GORDON FD, et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts[J]. Hepatology, 2000, 31(4): 864-871. DOI: 10.1053/he.2000.5852.
[11]	XAVIER SA, VILAS-BOAS R, BOAL CARVALHO P, et al. Assessment of prognostic performance of Albumin-Bilirubin, Child-Pugh, and Model for End-stage Liver Disease scores in patients with liver cirrhosis complicated with acute upper gastrointestinal bleeding[J]. Eur J Gastroenterol Hepatol, 2018, 30(6): 652-658. DOI: 10.1097/MEG.0000000000001087.
[12]	PORTE RJ, LISMAN T, TRIPODI A, et al. The International Normalized Ratio (INR) in the MELD score: Problems and solutions[J]. Am J Transplant, 2010, 10(6): 1349-1353. DOI: 10.1111/j.1600-6143.2010.03064.x.
[13]	KNOX JJ. Addressing the interplay of liver disease and hepatocellular carcinoma on patient survival: The ALBI scoring model[J]. J Clin Oncol, 2015, 33(6): 529-531. DOI: 10.1200/JCO.2014.59.0521.
[14]	LEI Q, ZHANG Y, KE C, et al. Value of the albumin-bilirubin score in the evaluation of hepatitis B virus-related acute-on-chronic liver failure, liver cirrhosis, and hepatocellular carcinoma[J]. Exp Ther Med, 2018, 15(3): 3074-3079. DOI: 10.3892/etm.2018.5748.
[15]	CHAN AW, CHAN RC, WONG GL, et al. New simple prognostic score for primary biliary cirrhosis: Albumin-bilirubin score[J]. J Gastroenterol Hepatol, 2015, 30(9): 1391-1396. DOI: 10.1111/jgh.12938.
[16]	ZOU D, QI X, ZHU C, et al. Albumin-bilirubin score for predicting the in-hospital mortality of acute upper gastrointestinal bleeding in liver cirrhosis: A retrospective study[J]. Turk J Gastroenterol, 2016, 27(2): 180-186. DOI: 10.5152/tjg.2016.15502.
[17]	LU JJ, ZHANG L, DING SG, et al. The prognosis of liver cirrhotic patients with acute esophageal variceal bleeding: A Cox regression analysis[J]. Chin J Dig, 2011, 31(4): 217-220. DOI: 10.3760/cma.j.issn.0254-1432.2011.04.001. 陆京京, 张莉, 丁士刚, 等. 肝硬化食管静脉曲张破裂出血患者预后Cox回归分析[J]. 中华消化杂志, 2011, 31(4): 217-220. DOI: 10.3760/cma.j.issn.0254-1432.2011.04.001.
[18]	CUI S, WANG F, LYU HM, et al. Value of Glasgow-Blatchford score in predicting early prognosis of cirrhotic patients with esophagogastric variceal bleeding[J]. J Clin Hepatol, 2017, 33(10): 1939-1943. DOI: 10.3969/j.issn.1001-5256.2017.10.018. 崔舒, 王芳, 吕洪敏, 等. Glasgow-Blatchford评分对肝硬化食管胃底静脉曲张破裂出血患者早期预后的预测价值[J]. 临床肝胆病杂志, 2017, 33(10): 1939-1943. DOI: 10.3969/j.issn.1001-5256.2017.10.018.

Relative Articles

Supplements(0)

Cited By

Cited by

Periodical cited type(14)

1.	李欣忆，李娇娇，李莹莹，魏虹合，熊雨凡，张新驰，孙蔚，陈丽. 基于APRI和PALBI构建的列线图对肝硬化并发食管胃底静脉曲张破裂出血的预测价值. 临床肝胆病杂志. 2024(03): 521-526 . 本站查看
2.	韩磊，苏宁，刘晓林，邬超. 基于DECT的碘斜率无创评估肝硬化患者肝功能的相关研究. 影像科学与光化学. 2024(02): 160-166 .
3.	韩磊，苏宁，邬超，杨佳敏，刘晓林. 基于DECT的NIC评估肝硬化患者肝功能分级的研究. 中国医疗设备. 2024(07): 124-128+135 .
4.	石红. 延续性护理服务方案对肝硬化食管胃静脉曲张内镜下精准断流术后的临床影响研究. 基层医学论坛. 2024(20): 114-116+142 .
5.	吴美儿，杨军勤，江新华，黄义华. 快速康复理念在肝硬化脾切除围术期护理中的应用. 现代诊断与治疗. 2024(08): 1233-1235+1238 .
6.	许娟，闫涛涛，李严锋，侯静涛，樊研. ALBI评分联合PCT在肝硬化腹水患者自发性细菌性腹膜炎的预测作用. 胃肠病学和肝病学杂志. 2023(01): 85-89 .
7.	王燕秋，周玲华，顾永梅，濮尊国. APRI、ALBI和AIMS65评分联合评价肝硬化EGVB病情程度和疾病预后的临床价值. 肝脏. 2023(12): 1430-1434+1439 .
8.	邓悦，姚欢，谢宇欣，石国庆. 肝硬化食管胃静脉曲张内镜下治疗后营养支持治疗的研究进展. 海南医学. 2022(04): 522-525 .
9.	高艳颖，张旭，李凤慧，向慧玲，梁静，刘华，吕洪敏，韩涛. 不同Child-Pugh分级肝硬化患者糖化白蛋白的测定及其应用价值. 临床肝胆病杂志. 2022(02): 347-351 . 本站查看
10.	李学勇，季云，孙沂，高怡. ALBI评分联合NLR在肝硬化食管胃底静脉曲张破裂出血预后中的作用. 现代消化及介入诊疗. 2022(05): 606-609 .
11.	廖翔. 肝硬化患者SAAG与食管胃底静脉曲张破裂出血的关系研究. 现代诊断与治疗. 2022(11): 1646-1648+1692 .
12.	郑秀丽，李静. RAR联合MELD评分对乙型肝炎肝硬化严重程度的评估价值. 锦州医科大学学报. 2022(05): 73-78 .
13.	黄义华，江新华，聂秋兰，万勇，谢文星，毛卫. 艾灸在肝硬化脾切除围术期ERAS理念中的应用. 中西医结合肝病杂志. 2022(12): 1140-1143 .
14.	孙秋，李广鉴，杜丽明，赵利，袁楠，张亚丽，曹立赢，陈朔华，任庆帅. 镜下不同分级肝硬化门静脉高压性胃病的临床特征和危险因素分析. 现代消化及介入诊疗. 2021(05): 639-642 .

Other cited types(6)

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Figures(2) / Tables(3)

Get Citation

PDF

XML

Article Metrics

Article views (879) PDF downloads(92)

Value of albumin-bilirubin score in predicting the prognosis of patients with liver cirrhosis and esophagogastric variceal bleeding

DOI: 10.3969/j.issn.1001-5256.2021.05.022